Difficulty: Medium
Average Score: 85%
Practice
Tumor lysis syndrome is a common complication during treatment of pediatric malignancies. Which malignancy is more likely to manifest such complication?
Correct answer
D
Rationale
In pediatric oncology, tumor lysis syndrome (TLS) is a serious complication that can occur during the treatment of malignancies due to the rapid breakdown of cancer cells. Burkitt lymphoma, which is a fast-growing type of non-Hodgkin lymphoma, is more likely to manifest TLS because of its high proliferation rate and sensitivity to chemotherapy. The rapid destruction of Burkitt lymphoma cells can lead to the release of large amounts of intracellular contents, such as potassium, phosphate, and uric acid, overwhelming the body's ability to eliminate them.
In contrast, the other malignancies listed in the options are less likely to result in TLS. Acute myelogenous leukemia (AML) is more associated with bone marrow involvement and may not lead to the same extent of tumor lysis as Burkitt lymphoma. Nephroblastoma (Wilms tumor) and neuroblastoma are solid tumors that are less prone to rapid cell turnover compared to hematologic malignancies like Burkitt lymphoma, making TLS less common in these cases.
From an educational perspective, understanding the risk factors for TLS in different pediatric malignancies is crucial for nurses and healthcare providers caring for pediatric oncology patients. Recognizing the malignancies that are more likely to manifest TLS can guide clinical management decisions, such as implementing preventive measures and close monitoring to prevent potential complications associated with TLS, such as renal failure, cardiac arrhythmias, and metabolic disturbances.
In contrast, the other malignancies listed in the options are less likely to result in TLS. Acute myelogenous leukemia (AML) is more associated with bone marrow involvement and may not lead to the same extent of tumor lysis as Burkitt lymphoma. Nephroblastoma (Wilms tumor) and neuroblastoma are solid tumors that are less prone to rapid cell turnover compared to hematologic malignancies like Burkitt lymphoma, making TLS less common in these cases.
From an educational perspective, understanding the risk factors for TLS in different pediatric malignancies is crucial for nurses and healthcare providers caring for pediatric oncology patients. Recognizing the malignancies that are more likely to manifest TLS can guide clinical management decisions, such as implementing preventive measures and close monitoring to prevent potential complications associated with TLS, such as renal failure, cardiac arrhythmias, and metabolic disturbances.